It was a good week for Merck as the Food and Drug Administration (FDA) has approved the company’s at-home Covid treatment. The agency gave the green light to the company’s antiviral pill to treat Covid-19 for emergency use on Thursday. Merck’s treatment, known as molnupiravir, was developed in partnership with Ridgeback Biotherapeutics. It is now … Continue reading “The FDA Has Cleared the Second At-Home Covid Treatment”
Tag: molnupiravir
Biotech & Pharma
Merck Shares Rise as Covid Antiviral Sales Could Mean Billions for the Company
Merck & Co. saw its shares rise on Thursday by over 5% as the company's…
October 29, 2021
Biotech & Pharma
Pfizer Begins to Dose Patients in its Oral Covid-19 Drug Trial
Pharmaceutical giant Pfizer has now started to dose patients in its oral COVID-19 drug trial.…
September 3, 2021